A participant in a recent FDA panel whose comments questioned Sarepta Therapeutics' methods has acknowledged to the Boston Business Journal that he neglected to mention a financial conflict of interest that could put his objectivity in doubt.

Harvard graduate student Michael Segal is trying to raise $30,000 on Kickstarter, much of which would be used to reach a deal with a Chinese manufacturer to product the digital photo frames, which would retail for about $120 each.

The CEO of Avid Technology, the Burlington company that was removed from the Nasdaq last year and then relisted earlier this year, earned more than $6.8 million in 2014, an increase from the previous year.